logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Communicating their individual results to participants in an environmental exposure study : Insights from clinical ethics.

    Article, Communication - En anglais

    Health Conference'97 - Great Lakes/St. Lawrence. Montréal, PQ, CAN, 1997/05/12.

    The objective of this study was to formulate a framework for determining what information to communicate to individual subjects of a study measuring biomarkers of exposure, consistent with the principles of ethical clinical and research practice.

    Methods consisted of review of the scope of environmental exposure studies, including the use of biomarker measurement in clinical medicine and environmental research and the relevant principles of clinical ethics and research practice.

    An exposure biomarker study is designed to elucidate constitutional, behavioral, and environmental determinants of tissue concentrations of exogenous substances.

    Of itself, it is not designed to measure risk relations, those being the relation between biomarker levels and health outcomes.

    In many settings, measured tissue biomarker concentrations fall below those known or reasonably predicted to cause disease.

    Ethical clinical and research practice, aiming to maximize autonomy and beneficence and to minimize harm, requires that study findings concerning the determinants of exposure be communicated to study participants.

    In addition, investigators should reference clinical action levels beyond which individual biomarker results are routinely communicated to participants.

    When biomarkers have no known relation to risk, or when levels fall below action levels, it may be preferable not to communicate individual results, if this arrangement has been formalized at the time of informed consent.

    Mots-clés Pascal : Santé et environnement, Ethique, Marqueur biologique, Facteur risque, Homme, Consommateur, Communication information, Produit pêche, Consommation alimentaire, Rivière, Milieu eau douce, Canada, Amérique du Nord, Amérique, Fleuve Saint-Laurent

    Mots-clés Pascal anglais : Health and environment, Ethics, Biological marker, Risk factor, Human, Consumer, Information communication, Seafood, Food intake, Rivers, Freshwater environment, Canada, North America, America

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0245463

    Code Inist : 002B30A01A2. Création : 16/11/1999.